From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.
- DOI
- 10.1007/s40259-026-00803-y
- Published
- 2026 Sep 19
- Container
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40259-026-00803-y,
title = {From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.},
author = {Capsius B and Pesic M and Niyazov R and Pippig S and Trieb M and Hole R and Balser S and Seidl A},
year = {2026},
journal = {BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy},
doi = {10.1007/s40259-026-00803-y},
url = {https://doi.org/10.1007/s40259-026-00803-y}
}RIS
TY - JOUR TI - From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate. AU - Capsius B AU - Pesic M AU - Niyazov R AU - Pippig S AU - Trieb M AU - Hole R AU - Balser S AU - Seidl A PY - 2026 JO - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy DO - 10.1007/s40259-026-00803-y UR - https://doi.org/10.1007/s40259-026-00803-y ER -
APA
B, C., M, P., R, N., S, P., M, T., R, H., S, B., & A, S. (2026). From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. https://doi.org/10.1007/s40259-026-00803-y
Source records
- pubmed · retrieved 2026-11-10T12:04:14.988Z